Introduction An Overview of Atopic Dermatitis Symptoms and Pathophysiology Diagnosis Prevalence Current Treatments Topical Corticosteroids Topical Immunosuppressants Antihistamines Current Market Drugs in Development Connetics’s Desonide and Clobetasol Propionate Arachnova’s AA-10006 Aerovance’s Pitrakinra Anacor Pharmaceuticals’ AN-0128 Corgentech’s Avrina Nucryst Pharmaceuticals’ NPI-32101 ProMetic Life Sciences’ rAAT and York Pharma’s Sabarep Market Outlook
Figure 1 The Itch-Scratch Cycle in Atopic Dermatitis
Table 1 Prevalence of Atopic Dermatitis in the Major Pharmaceutical Markets, 2005 and 2010 Table 2 Sales of Select Therapies for the Treatment of Atopic Dermatitis in the Seven Major Markets, 2005 Table 3 Emerging Agents for the Treatment of Dermatitis, 2006
